This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wilson, E. L. Articles by Reich, E. Search for Related Content PubMed PubMed Citation Articles by Wilson, E. L. Articles by Reich, E.

Modulation of Plasminogen Activator Synthesis in Chick Embryo Fibroblasts by Cyclic Nucleotides and Phorobol Myristate Acetate¹

The Rockefeller University, New York, New York 10021

To explore the interaction of tumor promoters and sarcoma virus transformation with cellular regulatory mechanisms, we have studied induction of plasminogen activator synthesis by these agents in a background of changing cyclic nucleotide concentrations. We have confirmed the original report of Wigler and Weinstein (Nature, 259: 232, 1976) that phorbol-12-myristate-13-acetate (PMA), a potent tumor promoter, induces high levels of plasminogen activator production by chick embryo fibroblasts. Sarcoma virus transformation sensitizes the fibroblasts by lowering the threshold concentration for response to the action of PMA, and the effects of transformation and PMA on plasminogen activator synthesis are synergistic rather than additive. The plasminogen activators produced in the PMA-, virus-induced, or synergistically stimulated cultures are indistinguishable. Enzyme production in all three conditions is strongly but reversibly inhibited when cyclic nucleotide levels are raised by exposure to cyclic adenosine-3':5'-monophosphate or cholera toxin. A substantial fraction of the morphological effect that accompanies transformation is not affected by concentrations of cyclic nucleotides that suppress plasminogen activator production, and the two phenomena are therefore at least partially independent expressions of transformation in this system.

¹ This work was supported in part by Grant ACS PDTII from the American Cancer Society and Grant CA-08290 from the National Cancer Institute, NIH, USPHS.

² Present address: Department of Clinical Science and Immunology, Medical School, University of Cape Town, Cape Town, South Africa.

³ To whom requests for reprints should be addressed, at the Rockefeller University, 1230 York Avenue, New York, N. Y. 10021.

Received 8/16/78. Accepted 1/23/79.

This article has been cited by other articles:

				H. Rubin Complementary approaches to understanding the role of proteases and their natural inhibitors in neoplastic development: retrospect and prospect Carcinogenesis, May 1, 2003; 24(5): 803 - 816. [Abstract] [Full Text] [PDF]